Articles tagged "Outcome"

2018 American Transplant Congress
Enhanced Recovery after Kidney Transplantation Regardless of Donor Organ Source
O. Ojogho,¹ S. BaniHani,¹ S. Nemr,¹ B. Dieter,² A. Joyce,¹ J. Mejia.¹
¹Providence Sacred Heart Medical Center and Children's Hospital, Spokane, WA; ²Providence Health Care, Spokane, WA.
BACKGROUND: Enhanced recovery after kidney transplantation is a desired outcome with potential value-enhancing benefits of reduced length of stay (LOS), costs, and risk of nosocomial…
2018 American Transplant Congress
Reliability of Bronchiolitis Obliterans Syndrome Reporting to the OPTN
R. Carrico,¹ R. Lehman,¹ K. Uccellini,¹ K. Chan,² T. Whelan.³
¹United Network for Organ Sharing, Richmond; ²Univ of Michigan, Ann Arbor; ³Medical Univ of South Carolina, Charleston.
Background: Chronic rejection of the lung allograft is traditionally classified as bronchiolitis obliterans syndrome (BOS) diagnosed by obstructive airway physiology. The OPTN requires the reporting…
2018 American Transplant Congress
Equivalent Clinical Outcomes and Stable Post-Operative Anti-A IgG Titers in A2 to B Renal Transplant Recipients Compared to Matched B to B Cohort
C. Barnhill,¹ P. Warner,² A. Weiss,¹ C. Kuhr,¹ N. Cowan,¹ J. Brandenberger.¹
¹Transplant, Virginia Mason Medical Center, Seattle; ²Immunogenetics/HLA Laboratory, Bloodworks Northwest, Seattle.
With the longest wait times and lowest rate of transplantation, ABO type B renal transplant candidates are at a disadvantage when compared to their type…
2018 American Transplant Congress
New SLK Allocation Policy May Impact Transplant Outcomes in Women
G. Cullaro,¹ R. Hirose,² J. Lai.¹
¹Medicine, University of California, San Francisco, San Francisco, CA; ²Transplant Surgery, University of California, San Francisco, San Francisco, CA.
Background: Previous SLK allocation was based on serum creatinine(Cr), a metric that disadvantaged women(W) relative to men(M). A SLK policy change utilizes eGFR, which accounts…
2018 American Transplant Congress
Belatacept Maintenance Immunosuppression Use and Outcomes in the Real-World Clinical Setting Using OPTN/UNOS Kidney Transplant Registry
S. Sanoff,¹ K. Ravindra,¹ W. Irish.^1,2
¹Duke University Medical Center, Durham, NC; ²CTI Consulting, Raleigh, NC.
Introduction:Belatacept (BEL) was FDA approved for Kidney Transplantation (KTx) June 2011. It has largely been evaluated in two controlled trials (N Engl J Med 2016;374:333-43).…
2018 American Transplant Congress
Serum Cytokines as Markers of Influenza Infection Outcomes after Transplantation
A. L'Huillier,¹ V. Ferreira,¹ C. Hirzel,¹ E. Cordero,² A. Limaye,³ G. Reid,⁴ J. Englund,³ E. Blumberg,⁵ A. Humar,¹ D. Kumar.¹
¹UHN, Toronto, Canada; ²REIPI, Seville, Spain; ³UOWMC, Seattle; ⁴LUMC, Chicago; ⁵UPenn, Philadelphia.
Background:Influenza infection in transplant patients can be severe but factors predictive of outcome in this setting are unclear. The aim of the study was to…
2018 American Transplant Congress
A Calculator for Kidney Transplant Waitlist Outcomes under the New Kidney Allocation System
A. Hart,^1,2 N. Salkowski,² A. Matas,³ B. Kasiske,² J. Snyder,² A. Israni.²
¹HCMC, Minneapolis; ²SRTR, Minneapolis; ³Univ of Minnesota, Minneapolis.
BACKGROUND: Outcomes on the kidney transplant waiting list vary markedly by region and patient characteristics, and the new kidney allocation system (KAS) changed the probability…
2018 American Transplant Congress
Efficacy and Safety of Tocilizumab in Treatment of Acute Antibody Mediated Rejection
K. Venkatachalam, D. Reem, M. Andrew, R. Delos Santos, T. Alhamad.
Transplant Nephrology, Washington University, Saint Louis, MO; Transplant Nephrology, Ohio State University, Columbus, OH; Transplant Nephrology, Washington University, Saint Louis, MO; Transplant Nephrology, Washington University, Saint Louis, MO.
Antibody mediated rejection continues to be one of the most detrimental complications of kidney transplant. Multiple therapeutic strategies focused on B cell and/or HLA antibody…
2018 American Transplant Congress
The Impact of Obesity on Incidence of Vascular Complications after Liver Transplantation: A Meta-Analysis
R. Deng, Y. Shi, B. Huang, Y. Ma.
Organ Transplantation Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Background: In response to the growing number of obese patients undergoing liver transplantation(LT), it is important to investigate the impact of obesity on post-transplant outcomes.…
2018 American Transplant Congress
Reducing Hospital Readmissions: Referral of High Risk Liver Transplant Patients to a Transitional Care Coordination(TCC) Program
A. Masoumi,¹ R. Barth,² T. Stern,¹ D. Bruno,² J. LaMattina,² S. Hanish.²
¹University of Maryland Medical Center, Baltimore, MD; ²Department of Surgery, University of Maryland School of Medicine, Baltimore, MD.
One-fifth of Medicare patients are readmitted to the hospital an annual cost of $17.4 billion. The readmission rate among liver transplant patient populations at a…